Disc Medicine (IRON) Total Non-Current Liabilities (2020 - 2023)
Disc Medicine's (IRON) quarterly Total Non-Current Liabilities came in at $16.0 million in Q3 2023, up 994.47% year-on-year from $1.5 million in Q3 2022, and up 39.88% on a QoQ basis from $11.5 million in Q2 2023.
Disc Medicine (IRON) Total Non-Current Liabilities (2020 - 2023) Analysis & Trends
Disc Medicine (IRON) has 4 years of Total Non-Current Liabilities data on file, last reported at $16.0 million in Q3 2023.
- On a quarterly basis, Total Non-Current Liabilities rose 994.47% year-over-year to $16.0 million in Q3 2023; TTM through Sep 2023 was $16.0 million, a 994.47% increase from a year earlier, with the FY2022 full-year figure at $23.6 million, up 76.71% from the prior year.
- Total Non-Current Liabilities for Q3 2023 stood at $16.0 million, up from $11.5 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for IRON reached as high as $29.9 million in Q4 2020 and fell as low as -$66000.0 in Q1 2020.
- Historically, Total Non-Current Liabilities has averaged $12.4 million across 4 years, with a median of $13.4 million in 2021.
- Across the five-year window, Total Non-Current Liabilities jumped 27228.79% in 2021 and sank 90.02% in 2022, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $29.9 million in 2020, then tumbled by 55.33% to $13.4 million in 2021, then soared by 76.71% to $23.6 million in 2022, then plunged by 32.12% to $16.0 million in 2023.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $16.0 million in Q3 2023, $11.5 million in Q2 2023, and $23.6 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 4.45 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 110.28 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.98 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 5.87 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 7.32 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 40.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 746.94 Mn |
| 10 | Disc Medicine | 2.89 Bn | 2.89 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 16.02 Mn |
| Jun 30, 2023 | 11.46 Mn |
| Dec 31, 2022 | 23.61 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 6.44 Mn |
| Mar 31, 2022 | 12.67 Mn |
| Dec 31, 2021 | 13.36 Mn |
| Sep 30, 2021 | 14.67 Mn |
| Jun 30, 2021 | 14.39 Mn |
| Mar 31, 2021 | 17.91 Mn |
| Dec 31, 2020 | 29.90 Mn |
| Jun 30, 2020 | -66,000.00 |
| Mar 31, 2020 | -66,000.00 |